English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Tuesday, October 1, 2024
Lexaria Appoints Michael Shankman as Chief Financial Officer
Friday, September 27, 2024
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #3
Thursday, September 5, 2024
Lexaria Releases Strategic Letter from the Outgoing CEO
Lexaria Welcomes Industry Veteran as New CEO
Tuesday, September 3, 2024
Lexaria Enters a Material Transfer Agreement for DehydraTECH Research
Thursday, August 29, 2024
Lexaria's Second GLP-1 Human Pilot Study Shows Zero Adverse Events in DehydraTECH-processed Rybelsus Oral Capsules
Tuesday, August 27, 2024
First Results From Lexaria's Second GLP-1 Human Pilot Study
Thursday, August 22, 2024
Positive 8-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study
Wednesday, August 21, 2024
Positive Interim Blood Sugar Results From Lexaria's GLP-1 Diabetes Animal Study
Monday, August 19, 2024
Positive Results from Lexaria's Molecular Characterization Study Monomeric form of GLP-1 drug preserved by DehydraTECH

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575